Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 3642-3650, December 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, S. K.
Right arrow Articles by Gelboin, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, S. K.
Right arrow Articles by Gelboin, H. V.

Kinetic Analysis of the Metabolism of Benzo(a)pyrene to Phenols, Dihydrodiols, and Quinones by High-Pressure Chromatography Compared to Analysis by Aryl Hydrocarbon Hydroxylase Assay, and the Effect of Enzyme Induction1

Shen K. Yang2, James K. Selkirk, Elliot V. Plotkin and Harry V. Gelboin

Arthur Amos Noyes Laboratory of Chemical Physics, California Institute of Technology,3 Pasadena, California 91125 [S. K. Y.], and Chemistry Branch, National Cancer Institute, NIH, Bethesda, Maryland 20014 [J. K. S., E. V. P., H. V. G.]

High-pressure liquid chromatography was used to analyze the rate of benzo(a)pyrene metabolite formation by liver microsomes from control and 3-methylcholanthrenetreated rats. The relative amounts of each metabolite formed were determined with several concentrations of microsomal mixed-function oxidases. The specific activity, i.e., amount formed per mg protein per min, was found to be constant for the formation of 3-hydroxybenzo(a)pyrene and 4,5-dihydro-4,5-dihydroxybenzo(a)pyrene. The specific activity for the formation of 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene was higher at high microsomal enzyme concentration. The formation of 9-hydroxybenzo(a)pyrene, however, did not increase with greater amounts of microsomes. The data indicate that 9-hydroxybenzo(a)pyrene is a nonenzymatic product derived from a reactive intermediate, probably benzo(a)pyrene-9,10-oxide. The relatively constant specific activity for the formation of 4,5-dihydro-4,5-dihydroxybenzo(a)pyrene with several enzyme concentrations suggests that the K-region epoxide, benzo(a)pyrene-4,5-oxide, is the most stable of the benzo(a)pyrene epoxide intermediates.

The relative percentages of each metabolite fraction found are as follows: 3-hydroxybenzo(a)pyrene, 36; 9-hydroxybenzo(a)pyrene, 3 to 13; 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene, 15 to 25; 4,5-dihydro-4,5-dihydroxybenzo(a)pyrene, 8; 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene, 12 to 14; benzo(a)pyrene quinones, 14 to 17. Induction of the enzyme system by 3-methylcholanthrene increases the amount of each metabolite formed to a different extent. The amount of 9,10-dihydro-9,10-dihydroxy- and 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene formed are markedly increased relative to the increase in the other metabolites. Thus the induction of the enzyme may specifically alter pathways of metabolism relevant to carcinogenesis. This study also makes a detailed comparison between the results obtained by high-pressure liquid chromatography analysis and the standard aryl hydrocarbon hydroxylase assay and further develops the chromatographic analysis of benzo(a)pyrene metabolites.

1 This research was supported in part by grants to Professor John D. Baldeschwieler from the National Science Foundation (Grant 38855X and NIH Grant GM 21111-02).

2 Visiting Associate in the Chemistry Branch, National Cancer Institute, NIH from November 1973 to March 1974.

3 Contribution 5031.

Received 5/ 5/75. Accepted 9/19/75.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Schwarz, P. Kisselev, and I. Roots
St. John's Wort Extracts and Some of Their Constituents Potently Inhibit Ultimate Carcinogen Formation from Benzo[a]pyrene-7,8-Dihydrodiol by Human CYP1A1
Cancer Res., November 15, 2003; 63(22): 8062 - 8068.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Schwarz, P. Kisselev, I. Cascorbi, W.-H. Schunck, and I. Roots
Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants
Carcinogenesis, March 1, 2001; 22(3): 453 - 459.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Yang, D. McCourt, J. Leutz, and H. Gelboin
Benzo[a]pyrene diol epoxides: mechanism of enzymatic formation and optically active intermediates
Science, June 10, 1977; 196(4295): 1199 - 1201.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.